MultiCell Technologies, Inc. (MCET)’in fiyatı nedir?

MultiCell Technologies, Inc. (MCET)’in fiyatı $0.00001’dir

MultiCell Technologies, Inc. (MCET)’in piyasa değeri nedir?

MultiCell Technologies, Inc. (MCET)’in piyasa değeri $50.01K’dir.

MultiCell Technologies, Inc. (MCET) Tedavüldeki Hisseler

MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprises MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a preclinical synthetic double-stranded RNA (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers; and MCT-485, a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of various cancers. The company also develops Ideal BioStent, a bioabsorbable stent for interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. has a license agreement with Corning Incorporated and Pfizer Inc. The company was formerly known as Exten Industries, Inc. and changed its name to MultiCell Technologies, Inc. in April 2004. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island.

Yıl	Tedavüldeki Hisse Sayısı	Değiştir
2026 (TTM)	5.14M	37.91%
2014	3.73M	94.37%
2013	1.92M	0.00%

Yıl

Tedavüldeki Hisse Sayısı

Değiştir

2026 (TTM)

5.14M

37.91%

2014

3.73M

94.37%

2013

1.92M

0.00%

Şirket	Tedavüldeki Hisse Sayısı	Fark	Ülke
Novo Nordisk A/S NVO.US	4.45B	86,456.88%	DK
Vertex Pharmaceuticals Incorporated VRTX.US	253.90M	4,840.99%	US
Regeneron Pharmaceuticals, Inc. REGN.US	102.90M	1,902.47%	US
UCB SA UCB.BR	190.00M	3,597.41%	BE
CSL Limited CSL.AX	483.58M	9,310.56%	AU

Şirket

Tedavüldeki Hisse Sayısı

Fark

Ülke